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ABSTRACT
Introduction: Coronary chronic total occlusions (CTO) represent a challenging subset in interventional
cardiology.
Areas covered: During the last decade, improvements in materials, techniques, and meticulous pre-
procedural lesion assessment have increased the success rate in CTO lesions. Several scores have been
developed to address overall lesion evaluation and help select the most appropriate treatment strategy.
In addition, specific algorithms such as the hybrid algorithm have been introduced to provide
a framework for CTO operators and a rapid management of the various challenging aspects of the
procedure. The hybrid approach requires operator’s ability to switch from one treatment strategy to
another when the first one appears to be unsuccessful. Adequate training and operators’ experience
remain crucial to improve the likelihood of success.
Expert opinion: The aim of this review is to provide insights and guidance for operators on current
approaches for treatment of CTO and complication management.
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1. Introduction
Chronic total occlusions (CTOs) are coronary segments
occluded for more than three months with TIMI grade flow 0
[1]. CTO remains one of the most challenging subsets for the
interventional community and a constant effort has been
made to develop dedicated tools and to improve techniques
[2,3]. Such continuous research translated into a high success
rate in experienced centers with a relevant reduction in the
occurrence of complications [4,5].
However, the optimal selection of patients and indication
for such procedures remain a subject of debate. Observational
data reported clinical benefit and improvement in quality of
life (QOL) associated with CTO treatment [6–9]. In addition
a recent meta-analysis showed improved survival in patient
with a successfully treated CTO, due to better left ventricular
function and remodeling [10].
On the other hand, two long awaited randomized trials the
EUROCTO trial and the DECISION-CTO trial reported an improve-
ment in angina frequency with a benefit in terms of QOL in
patients with CTO percutaneous coronary intervention (PCI) as
compared with optimal medical therapy (OMT) alone, but no
improvements in terms of overall mortality.
The latest European guidelines on myocardial revasculariza-
tion [11]** give a class IIa (Level of evidence B) recommendation
for CTO PCI, in particular in patients with expected ischemia
reduction in a corresponding myocardial territory and/or angina
relief, and suitable anatomy when performed by operators with
appropriate expertise. A retrograde approach via collateral ves-
sels is regarded as offering additional possibility of success after
failure of antegrade crossing and especially for right coronary
artery and left anterior descending (LAD) artery occlusions (Class
IIb, Level of evidence C). In addition, expert consensus docu-
ments have been produced on appropriateness of CTO PCI to
guide physicians in the decision making process while selecting
patients [12]**.
Once the patient has been properly evaluated and accepted
for CTO PCI, operators may face a complex intervention requiring
the knowledge of several techniques and a large armamentar-
ium of dedicated materials to maximize the chances of success.
As underlined in the EuroCTO consensus document of 2012, the
‘right operator choice’ is of utmost importance, since experience
and competence are directly related to procedure success.
Moreover, the art of ‘knowing when to stop’ should characterize
CTO-PCI operators, as they are required to be able to recognize
the moment to abandon the attempt of revascularization before
major complications occur [1].
With the present review, we aim at providing guidance and
insights on current technical approaches and strategies for
treatment of coronary CTOs and the management of possible
complications.
2. The patient with a coronary chronic total
occlusion
CTOs are observed in up to one third of patients undergoing
a non-emergent coronary angiography, while in patients
admitted for acute myocardial infarction (MI), CTO in a non-
infarct related artery (IRA) is reported in 10–15% [13–16].
Patients with CTOs often presented an impaired left ventricu-
lar function, prior MI, coronary artery bypass grafting (CABG),
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and a high rate of comorbidity, such as diabetes mellitus and
chronic kidney disease [13,14,17]. The presence of a CTO could
also increase the incidence of ventricular arrhythmias in survi-
vors of out-of-hospital cardiac arrest and in patients with
a CTO in IRA [18–20].
The real prevalence of CTOs among the general population
remains difficult to assess, given the presence of well-
developed collaterals that can mitigate symptoms [21].
3. Appropriateness of percutaneous
revascularization
Patients with coronary CTOs could be potentially treated with
OMT, or revascularization performed with either PCI or CABG.
Patients with a CTO and single vessel disease could benefit in
an early stage from OMT, as PCI never showed a reduction in
the risk of cardiac death and major adverse cardiovascular
events (MACE) in patients with low APPROACH and SYNTAX
scores [22,23]. Moreover, in elderly patients (≥75 years) and in
those suffering from diabetes the advantages of CTO PCI are
less evident [24,25].
On the other hand, successful CTO treatment (surgical or
percutaneously) was observed to improve disease perception,
angina frequency, and physical limitation compared with those
patients treated medically [26]. In particular, in patients with
multivessel disease, complete revascularization has been identi-
fied as a key factor to improve clinical outcomes and patient’s
QOL [27,28]. A sub-analysis of the of SYNTAX trial showed that
complete revascularization significantly decreased the incidence
of revascularization, MI, death and overall MACE. The same study
revealed that CTO was the most important independent predic-
tor of incomplete revascularization in patients with multivessel
disease treated with PCI [29] but not with CABG [30].
Appropriate Use Criteria (AUC), elaborated in 2009 and
updated in 2012, guide the process of decision-making among
the Heart Team in different clinical scenarios, including presence
of CTOs. In this case, symptom severity in maximal medical
treatment, ischemic burden, and viability demonstration are
discriminating factors. An expert consensus document reported
in 2016 the indications on appropriateness of CTO revasculariza-
tion according to symptoms, ischemia, and viability. In summary,
the presence of symptoms is considered the first factor to be
evaluated. In symptomatic patients with normal wall motion or
hypokinesia in the CTO territory, revascularization is suggested.
In symptomatic patients with akinesia or dyskinesia in the CTO
territory, CTO treatment could be considered after viability
demonstration. In asymptomatic patients the decision should
be, in general, guided mostly by the demonstration of viability
and ischemia. In particular an ischemic burden ≥10% should
suggest an invasive strategy [12]. Surgical revascularization
should be considered in patients with multiple CTOs and with-
out contraindications for surgery [27].
4. Morphological characteristics of CTO
CTOs consist of a proximal cap, often fibro-calcific, a body, and
a distal cap. The body frequently contains some degree of
neovascularization, dense fibrous tissue, atheroma, calcified
tissue, and focal lymphocyte infiltrate [31]. This type of lesions
could involve a long coronary segment with a large plaque
burden [32]. A study conducted by Guo et al. using intravas-
cular ultrasounds virtual histology (IVUS-VH) to evaluate CTO
lesion characteristics, revealed the presence of two relatively
different CTO plaque types: one presenting a large amount of
necrotic core, possibly deriving from ruptured plaques asso-
ciated with previous acute coronary syndromes, and the other
one characterized by a little or absent necrotic core, compa-
tible with slowly evolving plaques.
These findings suggest two possible mechanisms for CTO
formation, chronic occlusions could be the consequence of
either an acute coronary syndrome leading to an acute or
subacute coronary occlusion that later stabilizes or they
could derive from the slow progression of a large stable
atherosclerotic lesion to a total occlusion [33].
Such observation and the CTO composition could have an
impact on the PCI procedure as the presence of moderate/
severe calcification, in particular, is associated with a higher
use of the retrograde approach, lower success rates, and
higher incidence of complication [34]. Intra-plaque calcium
levels often reflect a long duration occlusion, while recent
lesions often present lower amount of calcium and higher
quantity of cholesterol and foam cells. Age-related changes
in plaque composition from lipid-rich to fibrocalcific might be
associated with lower success rate [35].
5. Evaluation and scoring of the CTO lesion
A comprehensive lesion evaluation represents a first step for
an appropriate treatment strategy. Morphology of the prox-
imal cap, length of the occlusion, distal target vessel, presence
of interventional collaterals, calcification, and tortuosity are all
relevant parameters to consider when planning a CTO
intervention.
Bilateral diagnostic coronary angiography is crucial for CTO
lesion evaluation and in selected cases Computed Tomography
for pre-procedural lesion assessment could be helpful [36].
Several scores have been developed with the aim of guid-
ing interventionalists in the choice of the best initial percuta-
neous approach on the basis of lesion characteristics (Table 1).
One of the most used scores is the J-CTO score, developed
from the Japanese Multicentre CTO Registry. Its primary objec-
tive is to predict successful guidewire crossing through a CTO
within 30 minutes. The J-CTO score takes into consideration
five parameters to assess procedure complexity: (1) tapered or
blunt proximal cap, (2) occlusion length ≥20 mm, (3) bending
Article highlights
● Percutaneous revascularization of CTOs should be considered in
patients with angina resistant to optimal medical therapy or with a
large area of documented ischemia in the territory of the occluded
vessel.
● Operator experience strongly influences success rates.
● The art of “knowing when to stop” is the key issue to avoid major
complications.
● Adequately powered, well designed, randomized trials are needed to
elucidate further benefit from CTO PCI.
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≥45°, (4) presence of calcifications, and (5) prior failed attempt.
Lesions are then classified as ‘easy, intermediate, difficult, and
very difficult’ [37]*. Different studies proved the validity of
J-CTO score in predicting success rates of CTO PCI, especially
in case of low J-CTO score [38,39].
The PROGRESS CTO (Prospective Global Registry for the
Study of Chronic Total Occlusion Intervention) score was
developed to predict technical success of CTO PCI performed
using the hybrid approach and it performed similarly to the
J-CTO score in estimating technical success. The PROGRESS
CTO score considers absence of collaterals, ambiguous cap,
involvement of the circumflex artery, and moderate/severe
tortuosity as predictors of unsuccessful CTO PCI [40].
The CL score (Clinical and Lesion–related score) has been
recently developed as a model predicting procedural success,
taking into account both clinical and angiographic characteristics
[41]. Such approach could improve accuracywhen comparedwith
other scores based only on lesion characteristics [42]. Recent
comparison of J-CTO, PROGRESS, and CL scores showed that
although the difference in technical success between the mini-
mum and maximum CL score strata is the highest, these scores
perform similarly in predicting technical success of CTO PCI, espe-
cially when antegrade wire escalation (AWE) is performed [43].
The EuroCTO CASTLE score was recently developed to pre-
dict technical success when performing CTO PCI. Six variables
(history of CABG, age, stump anatomy, tortuosity degree,
length of occlusion, and extent of calcification) were found
to be associated with unsuccessful procedure [44]. The
EuroCTO CASTLE score was comparable to the J-CTO score in
predicting CTO PCI outcomes, and for complex procedures it
provided a superior discriminatory capacity [45].
Considering that CTO PCI often requires a relatively high dose
of contrast, Liu et al. developed a score specific for estimating the
risk of contrast-induced nephropathy in patients undergoing
CTO PCI [46]. Four additional scores still pending validation
have been proposed the ORA (Ostial location, Rentrop grade,
Age), the B-CTO (Busan single-center registry), the Antegrade
CTO, and the RECHARGE (Registry of Crossboss and Hybrid
Procedures in France, the Netherlands, Belgium, and United
Kingdom) scores [47–50].
Two scores have been developed using Coronary Computer
Tomography Angiography (CTA), which have the advantage of
being a noninvasive assessment of CTO lesions and provide
a bilateral image of the coronary anatomy. Furthermore, CTA can
reveal specific morphologic properties, such as excessive bending
and calcium extension, which can be useful parameters for wire
escalation. TheCT-RECTOR score (Computed TomographyRegistry
of Chronic Total Occlusion Revascularization score) and the KCCT
score (KoreanMulticentre CTOCT Registry score)were observed to
be effective in the prediction of procedural duration [51,52].
Although, operator’s skills and experience are keys for the
success of the CTO intervention the above-mentioned scores
represent useful tools to evaluate the CTO lesions and can
guide the interventional strategy, in particular when consider-
ing the modality of AWE or the decision to immediately start
with a retrograde approach [53].
The above mentioned scores have been developed from
a relatively modest number of patients, except for the recent
EuroCTO CASTLE score validated from 20,000 patients of the
EuroCTO registry. The widely adopted J-CTO score was derived
from a cohort of 465 patients treated exclusively with the
antegrade approach between 2006 and 2007 with
a successful guidewire crossing within 30 minutes achieved
in 48% of the cases. Moreover, across the different registries
there was a great variance regarding the adopted recanaliza-
tion techniques, CTO PCI success rates, operator skills, and
case complexity making these scores poorly attractive for
a more generalized adoption.
These scores provide a quantitative evaluation of proce-
dural difficulty and the likelihood of recanalization success and
thus facilitate procedural planning. The novel EuroCTO CASTLE
scoring system combining additional demographic and anato-
mical factors might improve the prediction of procedural
outcome.
6. Antegrade and retrograde approaches
Before initiating a CTO PCI, lesion visualization with dual injection
is advisable in almost every case to ensure optimal lesion assess-
ment and since the lack of bilateral angiography is a predictor of
CTO PCI failure [54]. In selected cases and especially in absence of
relevant contralateral collateral and well-formed ipsilateral ones
a single injection and even retrograde ipsilateral intervention
strategy could be considered [55].
6.1. Antegrade approach
AWE is the most frequently performed technique, although it is
unlikely to be associated with a high success rate in complex cases
(J-CTO ≥ 1) [39,56]. Guidewires with different characteristics
(Hydrophilic/non-hydrophilic, polymer jacket, tapered, etc.) and
different penetration power (Tip Load/Tip Area) are used to cross
the lesion and could be alternated following a step-up/step-down
scheme [1,37,57]. As a general rule, CTO lesions with tapered
proximal cap and a high probability of having micro-channels
could be approached initially with soft hydrophilic taper wires
that could navigate the micro-channels and exit in the distal true
lumen. Although novel guide wires with a high maneuverability,
optimal torque response, and conic tip to improve penetrability
like the GAIA family of wires, profoundly improved the AWE tech-
nique, for more complicated lesions Karatasakis et al. demon-
strated that usually a large number of different guidewires is
needed to improve AWE success rate [58] and Maeremans et al.
proposed an algorithm to improve Antegrade Wire Technique
success rate, focusing on a guidewire alternating sequence [59].
To safely perform AWE technique, the operator should have
adequate experience in managing sub-intimal wire tracking
and should be able to promptly recognize wire exit from the
vessel structure. While misdirected even high tip-load guide-
wires could be associated with minor perforations, it is extre-
mely dangerous to advance a microcatheter or balloon over
a guidewire that has not been confirmed to be in the vessel
architecture, resulting in large vessel perforations and
tamponade.
In addition, changing the high tip load guidewires for
a safer one, once the lesion has been crossed, is necessary to
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avoid distal vessel complications [60]. In case of guidewire
entry into the subintimal space, it is possible to perform the
parallel wire technique. This technique consists of leaving the
first guidewire, in order to mark the dissection, and then
a second, usually with higher tip load is introduced to advance
in a different path. Although the recent introduction of new
types of guidewires has substantially improved the technique,
it can result in a time-consuming effort requiring specific skills
and experience [61]. Microcatheters are also of utmost utility
when performing different types of CTO-PCI techniques.
Principal microcatheter functions include guidewire exchange,
support and good positioning, contrast injection, and lumen
dilatation if needed. Moreover, double lumen microcatheters
allow the negotiation of collaterals and to preserve the whole
anatomy of occluded vessel with side branches in large parts
of the procedures [62].
Antegrade Dissection and reentry (ADR) technique consist-
ing of advancing in a dissection, and reentering the true
lumen distally could be preferred to the parallel wire techni-
que and could be very useful in case of an ambiguous prox-
imal cap and long lesion length provided the presence of
a distal vessel suitable for a reentry technique. ADR can be
wire-based or device based. Wire-based approaches include
STAR (Sub-intimal TrAcking and reentry), contrast injection
guided STAR, mini-STAR, and LAST (Limited Antegrade
Subintimal Tracking) techniques.
The STAR technique was proposed by Colombo et al. in
2005 for the antegrade treatment of CTOs following the exam-
ple of an approach already in use for chronic occlusions of
peripheral vessels. The STAR technique consists of using
a knuckle-wire to create a dissection, from which the true
lumen is eventually reentered [63]. The knuckle-wire is a safe
and effective technique when appropriate wires are used (soft
polymer jacketed); however, there is a high likelihood of creat-
ing a large sub-intimal hematoma, which makes reentry diffi-
cult because of true lumen compression. Furthermore, the
reentry location is often unpredictable and side branches are
at risk of occlusion [64].
Carlino et al. modified the STAR technique by introducing an
over the wire (OTW) balloon or microcatheter mediated contrast
injection in order to better visualize the reentry site [65]. Galassi
et al. further improved the STAR technique proposing the mini-
STAR technique, which consists of creating a dissection using
very soft guidewires (principally Fielder family) followed by
entering the subintimal space with a microcatheter, attempting
to reduce the subintimal hematoma and minimizing reentry
related complications [66]. Long-term follow-up of patients
who underwent mini-STAR showed an acceptable rate of MACE
and target lesion restenosis (TLR) [67].
The LAST technique, elaborated by Thompson and
Lombardi, requires a knuckle wire to create a dissection, and
then a polymer-jacketed wire or a non-jacketed stiff wire to
redirect toward the distal true lumen [68].
Overall, wire-based ADR has been associated with higher rest-
enosis rate, compared with standard PCI, probably in association
with the unpredictability of the reentry site, often translating into
long stented segment in the subintimal space. Such data empha-
sized the need for more controllable reentry techniques [69].
Figure 1. Controlled antegrade dissection and reentry technique. Long CTO of the right coronary artery with a clearly identifiable reentry point at initial angiograms
(panels a and b). Despite heavily calcification, the CrossBoss catheter advanced in the subintimal space, rapidly reached the desired reentry point (panel c) and
exchanged with a stingrey balloon (panel d), which was inflated facilitating the puncture toward the true lumen performed with the stingray wire (panel e). After
fenestration of the subintimal space the reentry can be performed with a standard hydrophilic wire (panel f, g, and h).
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Device based ADR is performed using dedicated devices,
such as the CrossBoss catheter and Stingray balloon (Figure 1).
The principal advantage of the Crossboss/Stingray combina-
tion is a subintimal tracking and a subsequent controlled
reentry. The CrossBoss is a microcatheter characterized by an
atraumatic rounded tip, this catheter must be advanced using
rapid rotation, with or without guide-wire, facilitating proximal
cap crossing, either passing through the lesion, and exiting
into the true lumen or entering the subintimal space. The
CrossBoss catheter given the atraumatic tip is designed to
remain in the structure of the vessel with a very low risk of
perforation. Such complication could occur in the case that
the microcatheter enters a small side-branch, but this issue
could be corrected retracting the microcatheter and re-
directing it with a high tip-load wire.
The Stingray reentry System includes a flat balloon with two
wire exit ports, one for each side, and another one located at the
tip. The balloon is advanced into the subintimal space up to the
desired site of reentry, where it is inflated at low pressure (4 atm).
The Stingray balloon given its flat morphology (2.5mmwide and
10 mm long) is self-orienting with one side port facing toward
the true lumen and the other toward the vessel wall unless a very
large hematoma is created. It is always advisable to minimize the
subintimal hematoma aspirating blood with the STRAW
(Subintimal TRAnscatheter Withdrawal) technique [70]. Then,
the Stingray wire characterized by a 28° tip angle and
a 0.18 mm needle located at the tip for lumen reentry is intro-
duced in the Stingray flat balloon and inserted into one of the
side exit ports in order to puncture the intima enabling reentry in
the true lumen. After the puncture has been performed the
reentry can be done with either the Stingray wire itself (‘stick-
and-drive’) or with another guidewire (‘stick-and-swap’) usually
a hydrophilic wire like the Pilot 200 [71]. This last is a safer
method especially if also the hydrophilic wire is later exchanged
for a workhorse wire before stenting. The FAST-CTOs trial
showed that this system is useful in case of standard technique
failure, possibly increasing success rates, without exposing
patients to higher complication rates [72]. The Stingray reentry
balloon has been designed to work in conjunction with the
Crossboss catheter; however, it could be effectively used also in
subintimal spaces created with a wire [73].
In case of ambiguous proximal cap or impenetrable lesion,
the BASE (Balloon Assisted Subintimal Entry) technique should
be considered as an option. This approach consists in entering
the subintimal space proximally to the proximal cap using the
aid of a slightly oversize balloon to create limited dissection.
Once the guidewire is passed through the lesion, it is possible
to proceed with a standard anterior dissection and reentry
[74]. The side-BASE technique is an evolution of the above-
mentioned one and it results useful in case of the presence of
a side branch located in proximity of a CTO lesion in a major
vessel characterized by an ambiguous or impenetrable prox-
imal cap. The first step is to create a proximal tear in the vessel
using a balloon and placing a microcatheter in the proximal
vessel using a second guidewire. After that, a second balloon
is partially inflated into the side branch in order to deflect and
anchor the wire to the microcatheter, so that the wire can be
pushed beyond the inflated balloon and pass the proximal
cap, usually within the subintimal space. As described for the
BASE technique, the procedure could be concluded with ante-
rior dissection and reentry technique [75].
6.2. Retrograde approach
Retrograde approaches include true-to-true lumen crossing
and dissection and reentry techniques.
The retrograde approach has been proposed in 2005 by
Katoh et al. with the aim of treating CTOs with ambiguous
proximal cap and diffusely diseased vessel [76]. To perform
a retrograde approach it is possible to use a connection between
the distal segment of the occluded vessel and another coronary
artery. This connection can be a septal, an epicardial collateral, or
a coronary bypass graft. Septal collaterals should always be
preferred to epicardials due to their intramuscular course redu-
cing the risk of complications.
Commonly used wires for septal crossing are soft hydro-
philic wires like the SION wire (soft tip 0.7 gf), with a dual-core
technology improving tip control and the full tip hydrophilic
coating (Slip Coat® technology). The SION Blue wire (softer tip
0.5 gf) with also a dual-core technology has a hydrophobic tip
coating (15 mm) which on one hand improves safety but on
the other makes small and tortuous septal crossing more
challenging. The SION Black is the polymer-jacket version of
the SION family (0.8 gf tip load) with the highest tip load but
good flexibility which make this wire a good option for small
channels and vessels although the likelihood of wire exit is
slightly higher compared with other non-polymer-jacked SION
wires [62].
Despite being in some cases visually appealing, epicardial
collaterals are associated with a higher risk of rupture leading
to cardiac tamponade, especially when tortuous and small in
diameter [77]. Therefore, retrograde treatment of CTOs using
epicardial collaterals should be preferably performed only by
experienced CTO operators. Nevertheless, novel devices, spe-
cifically designed for epicardial channel crossing, have been
recently developed, including low profile microcatheters
(ASAHI Caravel, Turnpike LP, etc.) and dedicated guidewires
like the ASAHI SUOH 03 characterized by an extremely soft pre
shaped tip with a tip load of only 0.3 gf, allowing a gentle
crossing of very tortuous epicardial collaterals [78].
Retrogradewires should always be followed by amicrocatheter
when located at the distal segment of a CTO to increase support
andallow safewire exchange. At that point theprocedure couldbe
finalized with retrograde wire escalation (RWE) or retrograde dis-
section and reentry (RDR).
RWE is similar to AWE; however, the distal cap is often less
calcified compared with the proximal one. Just as in AWE, the
use of a microcatheter support is pivotal in guidewire control
and advancement. After the guidewire has entered the true
lumen proximally to the CTO, the retrograde wire must enter
the antegrade guiding catheter followed by the microcatheter.
This manoeuver could be facilitated by a mother-and-child
guide catheter extension. Entrapping the retrograde wire
inside the antegrade guiding catheter (or the mother-and-
child guide catheter extension) could highly enhance the
support for the final advancement of the retrograde micro-
catheter. The guidewire can be then exchanged with an exter-
nalization wire and the PCI can be finalized [79]. In case of
946 G. IANNACCONE ET AL.
unfavorable anatomy alternative techniques should be con-
sidered. The tip-in technique consists in the advancement of
an antegrade microcatheter followed by the insertion of the
retrograde guide-wire in the tip of the antegrade microcath-
eter that can be further advanced up to the distal cap finaliz-
ing the procedure antegradely [80].
The success of RWE can sometimes be improved by the
‘kissing wire technique’ that requires the penetration of the
lesion both from the distal and the proximal cap. The techni-
que can aid to detect the vessel course more accurately, with
the antegrade wire acting as a marker.
The retrograde dissection and reentry techniques are per-
formed mainly with Controlled Antegrade and Retrograde
Subintimal Tracking (CART) and reverse CART (R-CART) [81]
technique. The CART and R-CART techniques involve the crea-
tion of a retrograde and antegrade subintimal space, typically
by using knuckle wires.
The R-CART is the more frequently adopted technique and
is performed as follows: the antegrade and retrograde knuckle
wires should overlap each other in the subintimal space, the
antegrade knuckle is then replaced by a workhorse wire and
a balloon is placed in the subintimal space. The antegrade
balloon should be inflated to connect the antegrade and
retrograde subintimal spaces. When deflating the balloon,
the retrograde wire, backed up by the microcatheter, is
steered toward the balloon entering the proximal true lumen
(Figure 2).
A slight retraction of the deflating balloon toward the prox-
imal vessel can facilitate the advancement of the retrograde wire
by creating a vacuum effect. This critical step involving proximal
reentry is defined as the ‘Deflate, Retract, and Advance into the
Fenestration Technique’ (DRAFT) proposed by Carlino et al. [82].
In the classic CART technique, CTO PCI is finalized using the
antegrade wire, with a retrograde balloon positioned in the
retrograde subintimal space to facilitate navigation [83]. Such
technique has been almost completely replaced in clinical
practice by the R-CART technique.
In case of balloon uncrossable or balloon undilatable
lesions rotational atherectomy can be considered to facilitate
catheter and guidewire crossing [84,85].
The retrograde is more commonly performed using the
collateral connections between the distal segment of the
occluded artery and a contralateral coronary vessel.
However, an alternative approach for retrograde CTO inter-
ventions, particularly useful in case of lack of contralateral
collaterals connections, is the crossing of ipsilateral collateral
channels (ILCs). A retrospective Multicenter Registry including
126 patients showed technical and procedural success rates of
87% and 82% when either septal or epicardial ILCs were used
to reach retrogradely the CTO lesion [86].
6.3. Hybrid approach
The recent introduction of the Hybrid Algorithm has been
a relevant novelty in the strategic approach to the treatment
of CTO lesions, combining conventional wire escalation to
more complex dissection and reentry techniques with use of
dedicated equipment. The algorithm has its flexibility and fast
shift from one approach to another its major strength [57]. The
four major techniques are AWE, Antegrade Dissection and
reentry (ADR), RWE, and RDR. Strategical planning is based
on lesion evaluation with dual injection angiography, allowing
an optimal visualization of the proximal cap but also of poten-
tial interventional collaterals, and the distal vessel. Such eva-
luation is guiding the decision on initial antegrade or
retrograde approach. Lesion length is then assessed to con-
sider the wire escalation or directly a dissection reentry tech-
nique. A non-ambiguous proximal cap and limited lesion
length (<20 mm) usually favors’ an AWE approach. If lesion
length is inferior to 20 mm an AWE can be performed with
good chances of success in a limited amount of time.
Antegrade dissection and reentry can be considered when
AWE is not successful, there is a suitable landing zone, and
unavailability of any retrograde options.
The presence of an ambiguous proximal cap and a poorly
defined distal landing zone (i.e. diffusely disease distal vessel,
distal cap at a bifurcation site, etc.), often drives the choice
toward a direct retrograde approach (Figure 3).
Rapid change from one strategy to another in case of fail-
ure is a key point of the Hybrid approach, but implies for the
CTO operator to be familiar with all possible techniques to be
able to choose the one with the highest probability of success
and to be ready to change it quickly in case of failure [57,87]*.
Hybrid Approach efficiency has been recognized from both
European and American Registries. The RECHARGE (REgistry of
Crossboss and Hybrid procedures in FrAnce, the NetheRlands,
Figure 2. Reverse CART technique. The antegrade and retrograde knuckle wires are advanced in two dissection plans (panel A). A mother-and-child catheter and
a balloon are advanced in the antegrade dissection and the balloon is inflated in the subintimal space to connect it with the retrograde subintimal space (panel B).
The retrograde wire is advanced up to the guiding catheter to be exchanged with an externalization wire (panel C). the finalization of the PCI is performed on the
externalization wire.
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BelGium, and UnitEd Kingdom) revealed success rates up to
86% and major in-hospital complication occurrence set to
2.6% [88]. Likewise, a US multicenter registry showed technical
success in 91% of cases and major procedural complications in
1.7% of performed CTO PCI [89].
7. Complications management
CTO procedure has been classically regarded as a procedure
with a higher rate of complications compared to PCI in non-
chronically occluded vessels [90].
Recent advancements in techniques and materials have dras-
tically reduced the occurrence of complications. However,
operators should be prepared to face and properly treat them.
In general PCI-related complications could be: (1) coronary
artery related, including coronary perforation, coronary throm-
bosis and occlusion, and equipment loss or entrapment; (2)
cardiac non-coronary, such as ventricular arrhythmias, cardiac
tamponade, and periprocedural MI; and (3) non-cardiac,
among which vascular access complications, systemic emboli-
zation, allergic reactions, contrast-induced nephropathy, and
radiation-induced injury. The management of such complica-
tions should be part of the technical background of every
interventional cardiologist.
Specific complications of CTO interventions particularly
when adopting a retrograde strategy are (1) donor vessel
damage or thrombosis, and (2) collateral perforations [60].
A simple measure to prevent donor vessel complications is
to avoid deep ostial intubation of the guiding catheter espe-
cially when retracting equipment from collaterals.
The presence of a microcatheter in a donor vessel with
intermediate stenosis could impair the blood flow possibly
causing ischemia and an unstable hemodynamic condition.
Therefore, the status of the donor vessel should be carefully
evaluated before adopting a retrograde strategy.
Finally, materials located in the donor vessel for
a prolonged time could prompt the occurrence of thrombosis.
Regular activated clotting time (ACT) controls should be per-
formed with a target ACT of >350 s.
Collateral perforation could be a challenging complication
especially after the chronically occluded vessel has been trea-
ted as the collaterals receive blood from the donor vessel and
from the treated CTO artery. In this situation, simple balloon
occlusion of one of the two arteries will not stop the bleeding.
Therefore, Microcoils embolization should be immediately
considered [91] or as alternatives autologous fat embolization.
Recently, autologous fat embolization has gained in popular-
ity, as this technique has no costs, is safe, and relatively easy to
perform [92]. Another possibility is to inject a mixture of
thrombin and contrast into the perforated vessel, using
a microcatheter to avoid thrombin entry in a coronary vessel
other than the intended [93].
As a general safety measure, a wire should be maintained
in the collaterals used for retrograde approach up to the end
of the procedure and an angiographic control should be
Figure 3. Hybrid approach. The hybrid approach is based on accurate lesion evaluation to guide initial strategy followed by rapid switch to another in case of failure.
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performed before removing it. In case of vessel damage/per-
foration the presence of the wire will allow a fast treatment of
the collateral.
8. Short and long term results of CTO-PCI
Recent improvements in CTO PCI techniques and materials have
increased success rates and reduced complication occurrence,
reducing the gap with non CTO PCI [4,21]. Since the introduction
of the Hybrid Approach, both American and European registries
showed procedural success rates reaching 90% in high volume
and experienced centers, with low rates of in-hospital major
adverse events and procedural complications [88,89]. The OPEN-
CTO registry revealed in-hospital and 1-month mortality rates
0,9% and 1,3%, respectively, with perforation occurring in 4,8%
of cases [17]. Long-term benefits fromCTO PCI in terms of QOL in
symptomatic patients have been reported in the FACTOR trial
and other studies. Werner and Jang showed that in asympto-
matic patients, cardiac function improvements post-CTO PCI are
relevant [9]. CTO treatment could also increase reverse remodel-
ing and decrease the risk of ventricular arrhythmias, even in older
patients [6,7,9,18,94]. The CREDO-Kyoto registry demonstrated
that successful CTO-PCIs are associated with less need for sub-
sequent CABG with respect to unsuccessful ones, while no dif-
ference was highlighted in terms of 3-year mortality [95]. Other
studies, instead, revealed an improved long-term survival in
patients undergoing successful CTO PCI [10,96], in particular
when a CTO in the LAD artery was treated [97,98].
Recently, the results of two long awaited randomized trials
have been made available, namely the DECISION CTO trial and
the EuroCTO trial.
The DECISION CTO trial is a prospective, open-label, rando-
mized trial carried out in 19 centers in Korea, India, Taiwan, and
Thailand. Patients eligible for PCI were randomized to receive
either PCI or medical therapy in case of CTO-lesions with the
option for PCI of significant non-CTO lesions. The study included
patients with a coronary chronic total occlusionwith TIMI flow 0 of
at least 3 months of duration located in a proximal to mid epicar-
dial vessel with a reference diameter >2.5 mm, either causing
silent ischemia, stable angina, or acute coronary syndrome.
Major exclusion criteria were CTOs located in distal vessels, in
venous grafts, in-stent restenosis, left main segment involvement,
severe comorbidities, and left ventricular ejection fraction (LVEF)
<30% [99]*. The primary composite endpoint was the incidence of
death from any cause, repeat revascularization, stroke, periproce-
dural, or spontaneous MI at 5-year follow-up. As a result, no
statistically significant difference was detected between the two
groups (PCI + CTO 22.3% vs. PCI + OMT 29.3% after 5 years,
p = 0.11), thus suggesting the non-superiority of additional CTO
PCI compared with OMT alone.
However, this trial had several limitations, the study was
prematurely terminated due to slow enrollment, out of the
planned sample size of 1284 patients only 834 were included.
Periprocedural MI an event possible only in the PCI arm was
included in the primary combined endpoint, a significant cross-
over was observed, namely 18% from the OMT arm to the PCI
arm. Finally, overall mortality in the PCI armwas lower than in the
OMT arm (3.0% vs. 4.4% at 3 years follow-up, and 4.5% vs. 7.9% at
5 years follow-up), with a reduction of 50% in the particular case
of cardiac death at the 3rd year (1.9% vs. 3.6%) [100].
Similar to the DECISION CTO trial, the EuroCTO trial did not
reach the planned number of enrolled patients, namely 600
patients for the efficacy endpoint of QOL and 1200 for the
primary safety endpoint of MACE [101]*. A total of 396
patients were enrolled, 259 underwent CTO PCI and 127 trea-
ted only with OMT. At 12-month follow-up, CTO PCI demon-
strated to be effective in improving the QOL, reducing the
recurrence of angina, as assessed by the Seattle Angina
Questionnaire (SAQ) health status survey. The incidence of
MACE resulted similar in the two groups.
9. Conclusions
Treatment of CTO lesions has obtained high success rates in
the last decade and a low incidence of complications when
performed by experienced operators. Such results were
obtained with a continuous improvement of techniques and
dedicated materials. Recent studies suggest that CTO treat-
ment could improve patients’ QOL, while a real advantage in
terms of mortality has not been demonstrated in randomized
trials but only in registries. Appropriate patient selection and
operator skills following dedicated trainings for CTOs treat-
ment remain crucial.
10. Expert opinion
Chronic total occlusion has been classically regarded as
a challenging subset in the field of PCIs, burdened by high
complexity, low success rates, and increased procedural risk
compared to non-CTO interventions.
However, in the last decade the development of dedicated
tools and techniques has enlarged the therapeutic options for
patients with CTO especially in centers with dedicated CTO
operators and CTO programs.
Cost management, logistical organization and appropriate
operator training with high yearly CTO case volume are keys to
success when organizing a CTO program.
Contemporary optimal CTO percutaneous treatment
appears to be limited to centers with the capability to orga-
nize and sustain such effort.
In addition, CTO treatment has beenput into question as recent
trials failed to show a clear improvement in clinical event rates
despite an advantage in terms of QOL and symptoms.
Given this background, advanced CTO PCI still remains
a niche treatment performed by a limited number of experts
and the majority of interventional cardiologists are not familiar
with the numerous techniques related to such procedures.
Therefore, the present review aims at providing a basic
knowledge of the materials and strategies to apply during
CTO percutaneous interventions. Such knowledge represents
the essential background for every CTO operator. Practical
guidance by experts and constant up to date techniques and
knowledge of materials could further facilitate the learning
progression.
At the moment two things appear to be the major limita-
tions to a large widespread adoption of CTO complex
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interventions in the clinical practice: (1) the absence of solid
data elucidating the impact on clinical events and mortality of
CTO successful treatment in viable myocardial segments; (2)
the absence of programs for a specific training of CTO dedi-
cated operators.
In particular, the need for a well-designed large rando-
mized trial focused on appropriate indications for CTO inter-
ventions and evaluating the impact of successful CTO
revascularization is extremely needed to clarify the role and
appropriateness of these complex and expensive procedures.
Unfortunately, such a study has not been planned yet and
does not appear to be easy to perform, given multiple reasons
comprising, the limited number of patients presenting with
CTO, the limited number of large volume CTO expert centers,
and the large number of patients probably needed to carry
out such clinical research.
On the other hand, angina relief and improved QOL in
patients with CTO have been better investigated and repre-
sent at the moment the major reasons to perform CTO PCI.
Specific training programs for CTO percutaneous treatment
could enhance the general understanding and adoption of the
complex techniques often needed during CTO procedures.
Such training should not be limited to congresses or live –
cases symposia but operators should be practically guided
during CTO procedures through an increasing level of case
complexity to gradually acquire knowledge, skills, and confi-
dence, additionally familiarizing themselves with the most
appropriate case-by-case complication management.
Finally, particularly interesting are the technological advance-
ments in terms of materials and tools for CTO treatment.
New guidewires such as the GAIA family provide an
improved operability when entering severe calcifications,
with an increased strength against the fracture, better linear
torque response, and maintaining the flexibility of the tip. In
addition GAIA Next (XTRAND coil) has the same basic structure
of the current Gaia, with an innovative structure of the rope
coil that consist of seven wires, and each wire is braided in
seven thinner wires. Three different tip loads are available
(2.0 – 4.0 – 6.0 gf) for different lesion properties.
The recent low profile dual lumen micro-catheters
(FineDuo, Sasuke) provide support and easy access to tortuous
coronary anatomies, or acute angulated lesions, and stronger
penetration force in complex procedures requiring greater
force transmission, compared to a conventional microcatheter.
The development of dedicated polymer jacket and hydro-
philic coating knuckle wire, such as the new Gladius Mongo
and Gladius Mongo ES (ASAHI) could be associated with
enhanced performance given the increased lubrication, track-
ability and torque transmission.
During the last years we have witnessed to an increased
use of IVUS-guidance in PCI of CTO lesions. IVUS provides
information on the vessel size, calcium distribution, precise
location of the guidewires within the architecture of the
artery, and could be critical for proximal cap identification in
case of ambiguity, potentially reducing perforation risk. After
stenting, IVUS allows evaluation of device expansion, apposi-
tion, and edge dissection, leading to procedural optimization.
The use of IVUS guidance has been reported to improve
clinical outcomes in large ‘all comers’ PCI populations and it
could be reasonably speculated that in highly complex proce-
dures like CTO the additional value of IVUS guidance could be
even more evident [102,103].
In the last years, the development of clinical robotic sys-
tems from the first Navicath to the most advanced CorPath
GRX System (Corindus Vascular Robotics) allowed perfor-
mance of remote coronary artery interventions. The PRECISE
(Percutaneous Robotically-Enhanced Coronary Intervention)
study evaluated simple lesions that needed treatment with
a single stent showing technical and procedural success rates
of 98.8% and 97.6%, respectively, in addition to a 95.2%
radiation dose reduction for the operators [104]. In 2015,
the CORA-PCI Study demonstrated the safety and feasibility
of performing robotically assisted PCI in a cohort of patients
with complex coronary anatomy and significant comorbid-
ities, including CTO [105]. Moreover, the REMOTE-PCI study
introduced the concept of PCI performed robotically by an
operator not physically located in the cathlab [106]. However,
robotically assisted PCI remains a poorly explored field and at
the current state of the art operator experience and skills
remain key in complex CTO procedures.
10.1. Five-year view
Coronary interventions for CTO lesions emerged in the last
years from high risk procedures burdened by low success and
high complication rates to a relatively safe and effective treat-
ment option. Major advancements in strategies and dedicated
tools have been instrumental in this evolution.
The development of CTO dedicated materials comprising
a large number of innovative guidewires and microcatheters
has changed the CTO PCI landscape. The traditional wire
escalation has been profoundly changed by the new pre-
shaped high torque response wires, whilst failure of wire
base reentry can be overcome using tools for controlled reen-
try. The recent introduction of ultra-low tip-weight wires has
yielded positive feedback on the crossing of epicardial chan-
nels, possibly increasing safety when using this, high-risk
option for a retrograde approach. In addition, the introduction
of the hybrid approach added efficiency to complex CTO
procedures.
Despite all these technical improvements, the future chal-
lenges for this ultraspecialistic field in interventional cardiol-
ogy remain clarification of the clinical implication of
a successful CTO PCI and dissemination of the CTO PCI
techniques.
In particular, although an improvement in QOL has been
shown after treatment of patients with ischemia/viability in
the territory of the chronically occluded vessel, an appropriate
evaluation of the prognostic impact of such procedure
remains a major issue and large appropriately powered and
well-designed randomized trials are highly needed.
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